RNFT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.222200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.073350E-01
Normal-vs-Stage2
7.365100E-04
Normal-vs-Stage3
1.045750E-01
Normal-vs-Stage4
1.836560E-01
Stage1-vs-Stage2
5.304400E-01
Stage1-vs-Stage3
1.229410E-01
Stage1-vs-Stage4
7.897600E-01
Stage2-vs-Stage3
1.087570E-01
Stage2-vs-Stage4
3.610600E-01
Stage3-vs-Stage4
5.485800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.243400E-04
Normal-vs-AfricanAmerican
2.900400E-01
Normal-vs-Asian
8.070300E-02
Caucasian-vs-AfricanAmerican
1.090800E-01
Caucasian-vs-Asian
9.772200E-01
AfricanAmerican-vs-Asian
2.551800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.120260E-03
Normal-vs-Female
9.846500E-04
Male-vs-Female
1.566980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.411820E-01
Normal-vs-Age(41-60Yrs)
1.193940E-02
Normal-vs-Age(61-80Yrs)
1.601220E-04
Normal-vs-Age(81-100Yrs)
9.357700E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.466200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.225600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.487400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.594100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.795900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.852200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.823200E-03
Normal-vs-Daily Drinker
1.323630E-01
Normal-vs-Weekly Drinker
1.980190E-03
Normal-vs-Occasional Drinker
1.234190E-02
Normal-vs-Social Drinker
4.958200E-03
Non Drinker-vs-Daily Drinker
3.670600E-01
Non Drinker-vs-Weekly Drinker
8.429400E-01
Non Drinker-vs-Occasional Drinker
5.427400E-01
Non Drinker-vs-Social Drinker
4.534800E-01
Daily Drinker-vs-Weekly Drinker
4.807000E-01
Daily Drinker-vs-Occasional Drinker
1.237570E-01
Daily Drinker-vs-Social Drinker
6.259700E-02
Weekly Drinker-vs-Occasional Drinker
4.282800E-01
Weekly Drinker-vs-Social Drinker
2.821800E-01
Occasional Drinker-vs-Social Drinker
8.958400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.463600E-01
Normal-vs-Grade 2
1.852830E-01
Normal-vs-Grade 3
1.754850E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.448000E-01
Grade 1-vs-Grade 3
5.182400E-01
Grade 1-vs-Grade 4
2.463600E-01
Grade 2-vs-Grade 3
8.344200E-01
Grade 2-vs-Grade 4
1.852830E-01
Grade 3-vs-Grade 4
1.754850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.189100E-04
Normal-vs-NonDiabetic
3.427500E-04
Diabetic-vs-NonDiabetic
4.228800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.643800E-02
Normal-vs-NoPancreatitis
1.201350E-04
Pancreatitis-vs-NoPancreatitis
6.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.288060E-02
Normal-vs-N1
2.049000E-04
N0-vs-N1
6.730000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.637910E-04
Normal-vs-TP53-NonMutant
7.202000E-03
TP53-Mutant-vs-TP53-NonMutant
2.931700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
